CCUURRRRIICCUULLUUMM VVIITTAAEE
`MMAANNSSOOOORR MM.. AAMMIIJJII,, PPhhDD,, RRPPhh
`
`CONTACT INFORMATION
`
`
`
`
`Office:
`Department of Pharmaceutical Sciences
`
`
`School of Pharmacy
`
`Bouve College of Health Sciences
`
`Northeastern University
`
`
`140 The Fenway Building, R156
`
`
`360 Huntington Avenue
`
`
`Boston, MA 02115
`
`
`Voice #: (617) 373-3137
`
`Fax #: (617) 373-8886
`
`E-mail: m.amiji@neu.edu
`Website: http://www.northeastern.edu/amijilab
`
`
`EDUCATION AND TRAINING
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Residence:
`195 Richie Road
`Attleboro, MA 02703
`Phone #: (508) 222-3034
`Mobile #: (617) 839-9679
`
`
`
`
`September, 1984 - June, 1988: Undergraduate Student in the College of Pharmacy and Allied Health Professions,
`Northeastern University, Boston, MA.
`
`
`September, 1986 - May, 1988: Undergraduate Honors Student Research Project Entitled “Preparation and
`Characterization of Doxorubicin-Dextran Conjugates” – Major Advisor: Professor Mehdi Boroujerdi.
`
`
`June, 1988: Bachelor of Science in Pharmacy (magna cum laude).
`
`
`
`August, 1988 - July, 1992: Doctoral Student in the Department of Industrial and Physical Pharmacy, School of
`Pharmacy and Pharmacal Sciences, Purdue University, West Lafayette, Indiana.
`
`
`August, 1988 - June, 1989: Teaching Assistant in the Department of Industrial and Physical Pharmacy.
`
`July, 1989 - June, 1992: Research Assistant in the Department of Industrial and Physical Pharmacy.
`
`July, 1989 - June, 1992: Doctoral Dissertation Research Entitled “Surface Modification of Biomaterials with Water-
`Soluble Polymers: A Steric Repulsion Approach” - Major Advisor: Professor Kinam Park.
`
`
`July, 1992: Doctor of Philosophy in Pharmaceutical Science/Pharmaceutics.
`
`PROFESSIONAL AND ACADEMIC POSITIONS
`
`August, 1992 – December, 1992: Senior Research Scientist, Columbia Research Laboratories, Madison, WI.
`
`January, 1993 – June, 1999: Assistant Professor, Department of Pharmaceutical Sciences, School of Pharmacy,
`Northeastern University, Boston, MA.
`
`
`July, 1999 – April, 2006: Associate Professor (with tenure), Department of Pharmaceutical Sciences, School of
`Pharmacy, Northeastern University, Boston, MA.
`
`
`
`TEVA - EXHIBIT 1003
`
`

`
`
`
`June, 2000 – December, 2000: Visiting Research Scholar. Department of Chemical Engineering, MA Institute of
`Technology, Cambridge, MA. (Sabbatical leave appointment in Institute Professor Robert Langer’s group).
`
` Amiji, M.M. - Page
`
`2
`
`
`
`
`
`
`
`
`May, 2006 – January, 2010: Full Professor, Department of Pharmaceutical Sciences, School of Pharmacy,
`Northeastern University, Boston, MA.
`
`
`February, 2010 – April, 2016: Present: Bouve College Distinguished Professor, Department of Pharmaceutical
`Sciences, School of Pharmacy, Northeastern University, Boston, MA.
`
`
`September, 2012 – Present: Affiliate Faculty Member, Department of Chemical Engineering, College of Engineering,
`Northeastern University, Boston, MA.
`
`
`September, 2013 – Present: Affiliate Faculty Member, Department of Biomedical Engineering, College of Engineering,
`Northeastern University, Boston, MA.
`
`
`January, 2014 – Present: Distinguished Adjunct Professor, Faculty of Pharmacy, King Abdulaziz University, Jeddah,
`Saudi Arabia.
`
`
`April, 2016 – Present: University Distinguished Professor, Department of Pharmaceutical Sciences, School of
`Pharmacy, Northeastern University, Boston, MA.
`
`
`ADMINISTRATIVE POSITIONS
`
`July, 1995 – June 2000: Pharmaceutics Group Leader, Department of Pharmaceutical Sciences, School of Pharmacy
`at Northeastern University, Boston, MA.
`
`
`September, 2002 – June, 2004: Education and Outreach Coordinator, Molecular Biotechnology Initiative at
`Northeastern University, Boston, MA.
`
`
`July 2003 – Present: Co-Director, Nanomedicine Education and Research Consortium (NERC) at Northeastern
`University, Boston, MA.
`
`
`July, 2005 – December, 2008: Associate Chairman, Department of Pharmaceutical Sciences, School of Pharmacy at
`Northeastern University, Boston, MA.
`
`
`January, 2009 – January, 2010: Interim Chairman, Department of Pharmaceutical Sciences, School of Pharmacy at
`Northeastern University, Boston, MA.
`
`
`February, 2010 – April, 2016: Chairman, Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern
`University, Boston, MA.
`
`
`RESEARCH INTERESTS
`
`The primary focus of research in my laboratory is on the development of biocompatible materials from natural and
`synthetic polymers, target-specific drug and gene delivery systems for cancer and infectious diseases, and
`nanotechnology applications for medical diagnosis, imaging, and therapy. Specific projects that we are currently pursuing
`include:
`
`
`
`
`

`
` Amiji, M.M. - Page
`
`
`
`
`• Synthesis of novel polymeric materials for medical and pharmaceutical applications.
`• Preparation and characterization of polymeric membranes and microcapsules with controlled permeability
`properties for medical and pharmaceutical applications.
`• Target-specific drug, gene, and vaccine delivery systems for diseases of the gastro-intestinal tract.
`• Delivery of DNA and siRNA to mucosal surfaces for gene therapy and vaccination.
`• Localized delivery of cytotoxic and anti-angiogenic drugs, siRNA, and genes for solid tumors in novel
`biodegradable polymeric nanoparticles.
`
`3
`
`•
`
`Intracellular and sub-cellular delivery systems for drugs and genes using target-specific, long-circulating,
`biodegradable polymeric nanoparticles.
`• Role of hypoxia and tumor microenvironment in development of tumor drug resistance, angiogenesis, and
`metastasis.
`• Local administration of drugs and nucleic acid-containing nanovectors immobilized on stents for the treatment of
`arterial diseases (e.g., coronary restenosis).
`• Novel oil-in-water nanoemulsion formulations for drug delivery through the gastrointestinal tract and across the
`blood-brain barrier.
`• Systemic and mucosal vaccination using novel immune-modulatory strategies and delivery systems.
`•
`
`Intranasal administration of liposomes and nanoemulsions to enhance brain delivery of peptides, proteins, siRNA,
`and genes.
`• Functionalized inorganic nanoparticles - including gold, iron oxide, alloys, and core-shell nanostructures - for
`biosensing, imaging, and targeted therapeutic applications.
`
`
`PUBLICATIONS [Google Scholar Hirsch “h” index = 65 and Thompson-Reuters Highly Cited (top 1%) in
`Pharmacology and Toxicology)]
`
`
`
`Book Editorship
`
`Amiji, M.M. and Sandmann, B.J. (eds.). Applied Physical Pharmacy. Published by McGraw-Hill Medical Publishing
`Division. New York, NY. 2002.
`
`
`Amiji, M.M. (ed.) Polymeric Gene Delivery: Principles and Applications. Published by CRC Press, LLC (a subsidiary of
`Taylor and Francis). Boca Raton, FL. 2004.
`
`
`Amiji, M.M. (ed.). Nanotechnology for Cancer Therapy. Published by CRC Press, LLC (a subsidiary of Taylor and
`Francis). Boca Raton, FL. 2007.
`
`
`Torchilin, V.P. and Amiji, M.M. (eds.). Handbook of Materials for Nanomedicine. Publication of the Biomedical
`Nanotechnology Series, (10 Volumes Book Series edited by Torchilin, V.P. and Amiji, M.M.). Volume 1, Pan
`Published by Stanford Publishing, Singapore, 2010.
`
`
`Amiji, M.M., Cook, T., and Mobley, W.C. (eds.). Applied Physical Pharmacy – Second Edition. Published by McGraw-Hill
`Medical Publishing Division. New York, NY, 2014.
`
`
`
`
`
`

`
`4
` Amiji, M.M. - Page
`
`
`
`
`Merkel, O.M. and Amiji, M.M. (eds). Advances and Challenges in the Delivery of Nucleic Acid Therapeutics – Volumes 1
`E-Book
`Published
`by
`Future
`Science,
`LTD,
`London,
`UK.
`2015.
`and
`2.
`http://www.futuremedicine.com/doi/book/10.4155/9781910419922.
`
`
`Milane, L. and Amiji, M.M. (eds). Nanotechnology in Inflammatory Diseases. To be Published by CRC Press, LLC (a
`subsidiary of Taylor and Francis). Boca Raton, FL. (In preparation).
`
`
`Book Chapters
`
`Amiji, M. and Park, K. Surface modification of polymeric biomaterials with poly(ethylene oxide): a steric repulsion
`approach. In Shalaby, S.W., Ikada, Y., Langer, R., and Williams, J. (eds.) Polymers of Biological and Biomedical
`Significance. American Chemical Society Symposium Series Publication, Volume 540. Published by the American
`Chemical Society, Washington, DC. 1994, pp 135-146.
`
`
`Amiji, M. and Park, K. Surface modification of polymeric biomaterials with poly(ethylene oxide), albumin, and heparin for
`reduced thrombogenicity. In Cooper, S.L., Bamford, C.H., and Tsuruta, T. (eds.) Polymer Biomaterials: In Solution,
`as Interfaces, and as Solids. Published by VSP, The Netherlands. 1995, pp 535-552.
`
`
`Amiji, M., Kamath, K., and Park, K. Albumin-modified biomaterial surfaces for reduced thrombogenicity. In Wise, D.L.,
`Altobelli, D.E., Grasser, J.D., Shwartz, E.R., Trantolo, D.J., and Yaszemski, M. (eds.) Encyclopedic Handbook of
`Biomaterials and Bioengineering - Part B Applications. Volume II. Published by Marcel Dekker, Inc., New York, NY.
`1995, pp 1057-1070.
`
`
`Amiji, M.M. Surface modification of chitosan to improve blood compatibility. In Pandalai, S.G. (eds.). Recent Research
`Developments in Polymer Science, Volume III. Published by Transworld Research Network, Trivandrum, India. 1999,
`pp 31-39.
`
`
`Hejazi, R. and Amiji, M. Chitosan-based delivery systems: physicochemical properties and pharmaceutical applications.
`In Dumitriu, S. (eds.). Polymeric Biomaterials. Second Edition, Revised and Expanded. Published by Marcel Dekker,
`Inc., New York, NY. 2001, Chapter 10, pp 213-238.
`
`
`Kaul, G. and Amiji, M. Polymeric gene delivery systems. In. Wise, D.L., Hasirci, V., Lewandrowski, K.-U., Yaszemski,
`M.J., Altobelli, D.W., and Trantolo, D.J. (eds.). Tissue Engineering and Novel Delivery Systems. Published by Marcel
`Dekker, Inc., New York, NY. 2004, Chapter 16, pp 333-367.
`
`
`Kommareddy, S. and Amiji, M. Targeted drug delivery to tumor cells using colloidal carriers. In Lu, D.R. and Oie, S.
`(eds.). Cellular Drug Delivery: Principles and Practice. Published by Humana Press, Inc., Totowa, NJ. 2004, Chapter
`10, pp 181-215.
`
`
`Kaul, G. and Amiji, M.M. Protein nanospheres for gene delivery. In Amiji, M.M. (ed.) Polymeric Gene Delivery: Principles
`and Applications. Published by CRC Press, LLC. Boca Raton, FL. 2004, Chapter 27, pp. 429-447.
`
`
`Kommareddy, S., Shenoy, D.B., and Amiji, M.M. Gelatin nanoparticles and their biofunctionalization. In Kumar, C. (ed.).
`Nanotechnologies for the Life Sciences, Volume 2: Biological and Pharmaceutical Nanomaterials. Published by
`Wiley-VCH, Berlin, Germany. 2005, Chapter 11, pp. 330-353.
`
`
`Bhavsar, M.D., Shenoy, D.B., and Amiji, M.M. Nanoparticles for delivery in the gastrointestinal tract. In Torchilin, V.P.
`(ed.). Nanoparticulates as Drug Carriers. Published by Imperial College Press, London, United Kingdom, 2006,
`Chapter 26, pp 609-648.
`
`
`
`

`
`
`
`Shenoy, D.B. and Amiji, M.M. An overview of condensing and non-condensing polymeric systems for gene delivery. In
`Friedmann, T. and Rossi, J (eds.). Gene Transfer: Delivery and Expression of DNA and RNA – A Laboratory Manual.
`Published by Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 2007, Chapter 34, pp 395-403.
`
` Amiji, M.M. - Page
`
`5
`
`
`
`
`
`
`
`
`Kommareddy, S. and Amiji, M.M. Protein nanospheres for gene delivery: preparation and in vitro transfection studies with
`gelatin nanoparticles. In Friedmann, T. and Rossi, J. (ed.). Gene Transfer: Delivery and Expression of DNA and RNA
`– A Laboratory Manual. Published by Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 2007, Chapter
`52, pp 527-540.
`
`
`Kommareddy, S., Shenoy, D.B., and Amiji, M.M. Long-circulating polymeric nanocarriers for drug and gene delivery in
`cancer. In Amiji, M.M. (ed.). Nanotechnology for Cancer Therapy. Published by CRC Press, Boca Raton, FL. 2007,
`Chapter 13, pp 231-242.
`
`
`Tiwari, S.B. and Amiji, M.M. Nanoemulsions for tumor targeted drug delivery. In Amiji, M.M. (ed.). Nanotechnology for
`Cancer Therapy. Published by CRC Press, Boca Raton, FL. 2007, Chapter 35, pp 723-739.
`
`
`Iftemia, N., Amiji, M.M., and Iftemia, I. Nanotechnology applications in cancer diagnosis and therapy. In Yih, T.C. and
`Talpasanu, I. (ed.). Micro and Nano Manipulations for Biomedical Applications. Published by Springer Publishing,
`New York, NY, 2008, Chapter 2, pp 13-41.
`
`
`Magadala, P., van Vlerken, L.E. Shahiwala, A., and Amiji, M.M. Multifunctional polymeric nanosystems for tumor-targeted
`delivery. In Torchilin, V.P. (ed.). Multifunctional Pharmaceutical Nanocarriers. Published by Springer Publishing, New
`York, NY 2008, Chapter 2, pp 33-64.
`
`
`Nagesha, D., Devalapally H.K., Sridhar, S., and Amiji, M. Multifunctional magnetic nanosystems for tumor imaging,
`targeted delivery, and thermal therapy. In Torchilin, V.P. (ed.). Multifunctional Pharmaceutical Nanocarriers.
`Published by Springer Publishing, New York, NY 2008, Chapter 14, pp 381-408.
`
`
`Bhavsar, M.B., Jain, S., and Amiji, M.M. Nanotechnology in oral drug delivery. In Xu, J. J. and Ekins, S. (eds.). Drug
`Efficacy, Safety, and Biologics Discovery: Emerging Technologies and Tools. Published by Wiley Publishing, New
`York, NY 2009, Chapter 10, pp. 231-275.
`
`
`Brito, L., Chadwick, S., and Amiji, M.M. Gelatin-based gene delivery systems. In Morishita, M. and Park, K. (eds.).
`Biodrug Delivery Systems: Fundamentals, Applications, and Clinical Developments”. Published by Informa
`Healthcare Group, New York, NY 2009, Chapter 20, pp 323-341.
`
`
`Ganta, S., Iyer, A.K., and Amiji, M.M. Multifunctional stimuli-responsive nanoparticles for delivery of small and
`macromolecular therapeutics. In Mahato, R.I. and Narang, A.S. (eds.). Targeted Delivery of Small and
`Macromolecular Drugs. Published by CRC Press, Inc., Boca Raton, FL, 2010 Chapter 20, pp 555-586.
`
`
`Iyer, A.K., Ganta, S., and Amiji, M.M. Polymeric nanoparticles as target-specific delivery systems. In Torchilin, V.P. and
`Amiji, M.M. (eds.). Handbook of Materials for Nanomedicine: Volume 1. Published by Pan Stanford Publishing,
`Singapore, 2010, Chapter 2, pp 81-130.
`
`
`Matthäus, C., Chernenko, T., Miljković, M., Quintero, L., Miljkovic, M., Milane, L., Kale, A., Amiji, M., Torchilin, V.,
`and Diem, M. Raman microspectral imaging of cells and intracellular drug delivery using nanocarrier systems. In
`Dieing, T., and Hollricher, O., and Toporski, J. (eds.). Confocal Raman Microscopy, Springer Series in Optical
`Science, Volume 158. Published by Springer Verlag, Heidelberg, Germany. 2010, pp. 137-163.
`
`
`
`

`
`
`
`Iftimia, N., Amiji, M., Milane, L., and Oldenburg, A. Nanotechnology approaches for contrast enhancement in optical
`imaging and disease targeted therapy. In Iftimia, N., Brugge, W., and Hammer, D.X (eds.). Advances in Optical
`Imaging for Clinical Medicine, Chapter 16. Published by Wiley Publishing, New York, NY. 2011. Chapter 16, pp 455-
`504.
`
` Amiji, M.M. - Page
`
`6
`
`
`
`
`
`
`
`
`Shahiwala, A., Vyas, T.K., and Amiji, M.M. Nanotechnology for targeted delivery of drugs and genes. In Nalwa, H.S. (Ed.).
`Encyclopedia of Nanoscience and Nanotechnology, 2nd Edition, Published by American Scientific Publishers, New
`York, NY. 2011. Volume 19, pp 265-295.
`
`
`Kalariya, M., Ganta, S., Attarwala, H., and Amiji, M. Multifunctional lipid nano-systems for cancer prevention and therapy.
`In Souto, E. (ed.). Advanced Anticancer Approaches with Multifunctional Lipid Nanocarriers. Published by iSmithers
`Rapra Publishing, Inc., Billingham, UK. 2011. Chapter 3, pp 29-54.
`
`
`Amiji, M.M. Hornicek, F., and Duan, Z.-F. Gene silencing with nanoparticle-encapsulated siRNA to overcome tumor
`multidrug resistance. In Srirajaskanthan, R. and Preedy, V.R. (eds.). Published by Nanomedicine and Cancer.
`Science Publishers-CRC Press, Enfield, NH. 2012. Chapter 15, pp 290-306.
`
`
`Jain, S. and Amiji, M. Macrophage-targeted nanoparticle delivery systems. In Pru’dhomme, R.K. and Svenson, S. (eds.).
`Multifunctional Nanoparticles for Drug Delivery Applications: Imaging, Targeting, and Delivery. Published by Springer
`Publishing, New York, NY. 2012 Chapter 4, pp 47-84.
`
`
`Jain, S. and Amiji, M. Target-specific chitosan-based nanoparticle systems for nucleic acid delivery. In Sarmento, B. and
`das Neves, J. (eds.) Chitosan-Based Systems for Biopharmaceuticals: Delivery, Targeting, and Polymer
`Therapeutics. Published by John Wiley & Sons Publishing, Chichester, West Sussex, UK. 2012 Chapter 15, pp 277-
`300.
`
`
`Singh, A., Chernenko, T., and Amiji. M. Theranostic applications of plasmonic nanosystems. In Hepel, M. and Zhong, C.J.
`(eds.). Functional Nanoparticles for Bioanalysis, Nanomedicine and Bioelectronic Devices. Volume 2. Published by
`American Chemical Society Publications, Washington, DC. 2012 Chapter 15, pp 383-413.
`
`
`Iyer, A., Ganesh, S., Zhou, Q.L., and Amiji, M. Multifunctional polymeric nano-systems for RNA interference therapy. In
`Wang., W. and Singh, M. (eds.) Biological Drug Products: Development and Strategies. Published by John Wiley
`Publishers, Nutley, NJ. 2013 Chapter 18, pp 569-600.
`
`
`Singh, A., Iyer, A., Ganta, S., and Amiji, M. Multifunctional nanosystems for cancer therapy. In Park, K. (ed.). Biomaterials
`for Cancer Therapeutics: Diagnosis, Prevention and Therapy. Published by Woodhead Publishing, Inc., Cambridge,
`UK. 2013 Chapter 14, pp 387-414.
`
`
`Chernenko, T., Milane, L., Matthäus, C., Diem, M., and Amiji, M. Raman microspectral imaging for label-free detection of
`nanoparticle-mediated cellular and sub-cellular drug delivery. In Li, C. and Tian, M. (eds.). Drug Delivery
`Applications of Non-Invasive Imaging: Validation from Biodistribution to Sites of Action. Published by John Wiley &
`Sons Publishing, Hoboken, NJ. 2013 Chapter 4, pp 70-90.
`
`
`Jain, S., and Amiji, M. Nanoparticles-in-microsphere oral systems (NiMOS) for nucleic acid therapy in the gastrointestinal
`tract. In Sarmento, B. and das Neves, J. (eds.) Mucosal Delivery of Biopharmaceuticals: Biology, Challenges and
`Strategies. Published by Springer Science Publishing, New York, NY. 2014 Chapter 11, pp 283-312.
`
`
`
`
`
`

`
`7
` Amiji, M.M. - Page
`
`
`
`
`Deshpande, D., Jamal-Allial, A., Sankhe, K., and Amiji, M. Nanotechnology applications in local arterial drug delivery. In
`Domb, A. and Khan, W. (eds). Advances in Delivery Science and Technology - Focal Controlled Drug Therapy.
`Published by the Controlled Release Society - Springer Science Publishing, New York, NY. 2014 Chapter 17, pp
`359-385.
`
`
`Ganesh, S., Iyer, A.K., and Amiji, M.M. Combinatorial-designed hyaluronic acid nanoparticles for tumor targeted drug and
`small interfering RNA delivery. In Collins, M. (ed.). Hyaluronic Acid for Biomedical and Pharmaceutical Applications.
`Published by Simthers Rapra, Shrewsbury, The United Kingdom. 2014 Chapter 3, pp 57-88.
`
`
`Iyer, A.K., Ganesh, S., and Amiji, M.M. Nano-platforms for tumor-targeted delivery of nucleic acid therapies. In Alonso,
`M.J. and Fuentes, M.G. (eds). Nano-Oncologicals: New Targeting and Delivery Approaches. Published by the
`Controlled Release Society - Springer Publishing, New York, NY. 2014 Chapter 10, pp 269-291.
`
`
`Singh, A., Oka, A.J., Pandya, P., and Amiji, M.M. Multimodal nano-systems for cancer diagnosis, imaging, and therapy. In
`Alonso, M.J. and Fuentes, M.G. (eds). Nano-Oncologicals: New Targeting and Delivery Approaches. Published by
`the Controlled Release Society - Springer Publishing, New York, NY. 2014 Chapter 13, pp 351-388.
`
`
`Singh, A., Iyer, A., and Amiji, M. Polymeric nano-systems for integrated image-guided cancer therapy. In V.P. Torchilin
`(ed.). Handbook of Nano-Biomedical Research: Fundamentals, Applications, and Recent Developments. Volume 1:
`Materials for Nanomedicine. Published by World Scientific Publishing, Singapore. 2014 Chapter 6, pp 199-233.
`
`
`Ganta, S., Singh, A., Coleman, T.P., Williams, D., and Amiji, M. Pharmaceutical nanotechnology: overcoming drug
`delivery challenges in contemporary medicine. In Ge, Y., Li, S., Wang, S., and Moore, R. (eds.). Nanomedicine:
`Principles and Perspectives - Volumes 1 & 2. Published by Springer Publishing, New York, NY. 2014 Chapter 10, pp
`191-236.
`
`
`Shah, R., Brito, L., Singh, M., O’Hagan, D., and, Amiji, M. Emulsions as vaccine adjuvants. In Foged, C., Rades, T.,
`Perrie, Y., and Hook, S. (eds). Subunit Vaccine Delivery. Published by the Controlled Release Society - Springer
`Publishing, New York, NY 2014 Chapter 4, pp 59-76.
`
`
`Shah, L., Iyer, A., Talekar, M., and Amiji, M. Image-guided delivery of therapeutics to the brain. In Devarajan, P. and Jain,
`S. (eds). Targeted Drug Delivery – Concepts and Design. Published by the Controlled Release Society - Springer
`Publishing, New York, NY 2015, Chapter 4, pp 151-178.
`
`
`Attarwala, H. and Amiji, M. Multi-compartmental oral delivery systems for oligonucleotide therapeutics. In Merkel, O.M.
`and Amiji, M.M. (eds). Advances and Challenges in the Delivery of Nucleic Acid Therapeutics – Volume 2. E-Book
`Published by Future Science, LTD, London, UK. 2015, Chapter 14, pp 71-86.
`
`
`Attarwala, H. and Amiji, M. Biodegradable polyester-based multi-compartmental delivery systems for oral nucleic acid
`therapy. In Majeti, R. (ed.). Handbook of Polyester Drug Delivery Systems. Pan Stanford Publishing, Singapore. (In
`press).
`
`
`Singh, A., Tran, T.H., and Amiji, M. Redox-responsive nano-delivery systems for cancer therapy. In V. Weissig and A.
`Prokop (eds.). Advances in Nanotherapeutics for Cancer. Volume 3. Published by Springer Publishing, New York,
`NY. 2016 (In press).
`
`
`Peer-Reviewed Articles
`
`
`
`

`
`8
` Amiji, M.M. - Page
`
`
`
`
`Amiji, M., Park, H., and Park, K. Study on the prevention of surface-induced platelet activation by albumin coating. Journal
`of Biomaterials Science, Polymer Edition, 3: 375-388 (1992).
`
`
`Amiji, M. and Park, K. Prevention of protein adsorption and platelet adhesion on surfaces by PEO/PPO/PEO triblock
`copolymers. Biomaterials 13: 682-692 (1992).
`
`
`Amiji, M. and Park, K. Surface modification by radiation-induced grafting of PEO/PPO/PEO triblock copolymers. Journal of
`Colloid and Interface Science, 155: 251-255 (1993).
`
`
`Amiji, M. and Park, K. Surface modification of polymeric biomaterials with poly(ethylene oxide), albumin, and heparin for
`reduced thrombogenicity. Journal of Biomaterials Science, Polymer Edition, 4: 217-234 (1993).
`
`
`Knuth, K., Amiji, M., and Robinson, J.R. Hydrogel delivery system for vaginal and oral applications: formulation and
`biological considerations. Advances in Drug Delivery Reviews, 11: 137-167 (1993).
`
`
`Amiji, M. and K. Park. Analysis on the surface adsorption of PEO/PPO/PEO triblock copolymers by radiolabelling and
`fluorescence techniques. Journal of Applied Polymer Science, 52: 539-544 (1994).
`
`
`Amiji, M.M. Permeability and blood compatibility properties of chitosan-poly(ethylene oxide) blend membranes for
`hemodialysis. Biomaterials, 16: 593-599 (1995).
`
`
`Amiji, M.M. Pyrene fluorescence study of chitosan self-association in aqueous solution. Carbohydrate Polymers 26: 211-
`213 (1995).
`
`
`Amiji, M., Shah, E., and Boroujerdi, M. Photophysical characterization of insulin denaturation and aggregation at
`hydrophobic interfaces. Drug Development and Industrial Pharmacy, 21: 1661-1669 (1995).
`
`
`Patel, V.R. and Amiji, M.M. pH-sensitive swelling and drug release properties of chitosan-poly(ethylene oxide) semi-
`interpenetrating polymer network. In R. Ottenbrite, S. Huang, and K. Park (eds.) Hydrogels and Biodegradable
`Polymers for Bioapplications. American Chemical Society Symposium Series Publication. Volume 627. American
`Chemical Society, Washington, DC. 1996, pp 209-220.
`
`
`Patel, V.R. and Amiji, M.M. Preparation and characterization of freeze-dried chitosan-poly(ethylene oxide) hydrogels for
`site-specific antibiotic delivery in the stomach. Pharmaceutical Research 13: 588-593 (1996).
`
`
`Amiji, M.M. Surface modification of chitosan membranes by complexation-interpenetration of anionic polysaccharides for
`improved blood compatibility in hemodialysis. Journal of Biomaterials Science, Polymer Edition, 8: 281-298 (1996).
`
`
`Amiji, M., Tailor, R., Ly, M., and Goreham, J. Gelatin-poly(ethylene oxide) semi-interpenetrating polymer network with pH-
`sensitive swelling and enzyme-degradable properties for oral drug delivery. Drug Development and Industrial
`Pharmacy, 23: 575-582 (1997).
`
`
`Amiji, M.M. Synthesis of anionic poly(ethylene glycol) derivative for chitosan surface modification in blood-contacting
`applications. Carbohydrate Polymers, 32: 193-199 (1997).
`
`
`Amiji, M.M. Platelet adhesion and activation on an amphoteric chitosan derivative bearing sulfonate groups. Colloids and
`Surfaces. Part B: Biointerfaces, 10: 263-271 (1998).
`
`
`
`
`
`

`
`9
` Amiji, M.M. - Page
`
`
`
`
`Qaqish, R.B. and Amiji, M.M. Synthesis of fluorescent chitosan derivative and its application for the study of chitosan-
`mucin interactions. Carbohydrate Polymers 38: 99-107 (1999).
`
`
`Shah, S., Qaqish, R., Patel, V., and Amiji. M. Evaluation of the factors influencing stomach-specific delivery of
`antibacterial agents for Helicobacter pylori infection. Journal of Pharmacy and Pharmacology, 51: 667-672 (1999).
`
`
`Anderson, D., Nguyen, T., and Amiji, M. Chitosan-Pluronic® physical interpenetrating network: membrane fabrication and
`protein permeability studies. In M. El-Nokaly and H. Soini (eds.). Polysaccharides in Pharmaceutical and Cosmetic
`Applications. American Chemical Society Symposium Series Publication, Volume 737. American Chemical Society,
`Washington, DC 1999, pp 178-186.
`
`
`McQueen, C., Silvia, A., Lai, P.K., and Amiji, M. Surface and blood interaction properties of poly(ethylene oxide)-modified
`chitosan microspheres. S.T.P Pharma Sciences. 10: 95-100 (2000). [Year 2000 thematic issue on “Chitosan in
`Drug Delivery Systems”].
`
`
`Anderson, D., Nguyen, T., Lai, P.K., and Amiji, M. Evaluation of the permeability and blood-compatibility properties of
`membranes formed by physical interpenetration of chitosan with PEO/PPO/PEO triblock copolymers. Journal of
`Applied Polymer Science, 80: 1274-1284 (2001).
`
`
`Anderson, D. and Amiji, M. Preparation and evaluation of sustained drug release from Pluronic® polyol rectal
`suppositories. International Journal of Pharmaceutical Compounding, 5: 234-237 (2001).
`
`
`Lynn, D.M., Amiji, M.M., and Langer, R. pH-responsive biodegradable polymer microspheres: rapid release of
`encapsulated material within the range of intracellular pH. Angewandte Chemie, International Edition, 40(9): 1707-
`1710 (2001).
`
`
`Amiji, M.M., Lai, P.-K., Shenoy, D.B., and Rao, M. Intratumoral administration of paclitaxel in an in situ gelling poloxamer
`407 formulation. Pharmaceutical Development and Technology, 7(2): 195-202 (2002).
`
`
`Hejazi, R. and Amiji, M. Stomach-specific anti-H. pylori therapy. I: Preparation and characterization of tetracycline-loaded
`chitosan microspheres. International Journal of Pharmaceutics, 235(1-2): 87-94 (2002).
`
`
`Nsereko, S. and Amiji, M. Localized delivery of paclitaxel in solid tumors from biodegradable chitin microparticle
`formulations. Biomaterials, 23(13): 2723-2731 (2002).
`
`
`Kaul, G. and Amiji, M. Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery.
`Pharmaceutical Research, 19 (7): 1062-1068 (2002).
`
`
`Kaul, G., Potineni, A., Lynn, D.M., Langer, R., and Amiji, M.M. Surface-modified polymeric nanoparticles for tumor-
`targeted delivery. surFACTS – Official Newsletter of Surfaces in Biomaterials Foundation. 7(2): 1-6 (2002).
`
`
`Chawla, J.S. and Amiji, M.M. Biodegradable poly(epsilon-caprolactone) nanoparticles for tumor-targeted delivery of
`tamoxifen. International Journal of Pharmaceutics, 249 (1-2): 127-138 (2002).
`
`
`Taqieddin, E., Lee, C., and Amiji, M. Perm-selective chitosan-alginate hybrid microcapsules for enzyme immobilization
`technology. Pharmaceutical Engineers – Journal of the International Society of Pharmaceutical Engineers. 22 (6):
`112-114 (2002).
`
`
`
`
`
`

`
`10
` Amiji, M.M. - Page
`
`
`
`
`Potineni, A., Lynn, D.M., Langer, R., and Amiji, M.M. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles
`as pH-sensitive biodegradable system for paclitaxel delivery. Journal of Controlled Release, 86: 223-234 (2003).
`
`
`Chawla, J.S. and Amiji, M.M. Cellular uptake and concentrations of tamoxifen upon administration in poly(epsilon-
`caprolactone) nanoparticles. The AAPS PharmSci, 5 (1): Article E3 (2003).
`
`
`Hejazi, R. and Amiji, M. Chitosan-based gastrointestinal delivery systems Journal of Controlled Release, 89: 151-165
`(2003). – Invited review.
`
`
`Hejazi, R. and Amiji, M. Stomach-specific anti-H. pylori therapy. II: Gastric residence studies of tetracycline-loaded
`chitosan microspheres in gerbils. Pharmaceutical Development and Technology, 8: 253-262 (2003).
`
`
`Kaul, G., Lee-Parsons, C., and Amiji, M. Poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery.
`Pharmaceutical Engineers – Journal of the International Society of Pharmaceutical Engineers. 23 (5): 108-114
`(2003).
`
`
`Taqieddin, E. and Amiji, M. Enzyme immobilization in novel alginate-chitosan core-shell microcapsules. Biomaterials, 25
`(10): 1937-1945 (2004).
`
`
`Hejazi, R. and Amiji, M. Stomach-specific anti-H. pylori therapy. III: Effect of chitosan microsphere crosslinking on the
`gastric residence and local tetracycline concentrations in fasted gerbils. International Journal of Pharmaceutics, 272
`(1-2): 99-108 (2004).
`
`
`Thatte, H.S., Zagarins, S.E., Amiji, M.M., and Khuri, S.F. Poly(N-acetyl-glucosamine)-mediated red blood cell interactions.
`Journal of Trauma – Injury Infection and Critical Care, 57(1): Supplement: S7-S12 (2004).
`
`
`Kaul, G. and Amiji, M. Biodistribution and targeting potential of poly(ethylene glycol) modified gelatin nanoparticles in
`subcutaneous murine tumor model. Journal of Drug Targeting, 12(9-10): 585-591 (2004).
`
`
`Kaul, G. and Amiji, M. Cellular interactions and in vitro DNA transfection studies with poly(ethylene glycol)-modified
`gelatin nanoparticles. Journal of Pharmaceutical Sciences 94 (1): 184-198 (2005).
`
`
`Shenoy, D.B. and Amiji, M.M. Poly(ethylene oxide)-modified poly(epsilon-caprolactone) nanoparticles for targeted
`tamoxifen delivery in breast cancer. International Journal of Pharmaceutics, 293: 261-270 (2005). [This publication
`was recognized with a Certificate of Most Cited Publication by the International Journal of Pharmaceutics, Elsevier
`publishing team].
`
`
`Kaul, G. and Amiji, M. Tumor-targeted delivery of plasmid DNA using poly(ethylene glycol)-modified gelatin nanoparticles:
`In vitro and in vivo studies. Pharmaceutical Research, 22(6): 951-961 (2005). [This publication was recognized for
`the 2007 Meritorious Manuscript Award from the American Association of Pharmaceutical Scientists].
`
`
`Shenoy, D., Little, S., Langer, R., and Amiji, M. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a
`pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: Part I. In vitro evaluations. Molecular
`Pharmaceutics, 2(5): 357-366 (2005).
`
`
`Kommareddy, S. and Amiji. M. Preparation and evaluation of thiol-modified gelatin nanoparticles for intracellular DNA
`delivery in response to glutathione. Bioconjugate Chemistry, 16 (6):1423-1432 (2005).
`
`
`
`
`
`

`
`11
` Amiji, M.M. - Page
`
`
`
`
`Shenoy, D., Little, S., Langer, R., and Amiji, M. Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a
`pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: Part II. In vivo biodistribution and tumor
`localization studies. Pharmaceutical Research, 22(12): 2107-2114 (2005).
`
`
`Kommareddy, S., Tiwari, S., and Amiji, M.M. Long-circulating nanovectors for tumor-specific gene delivery. Technology in
`Cancer Research and Treatment, 4(6): 615-625 (2005). [Invited review in the special issue on “Nanotechnology in
`Cancer Detection and Treatment”].
`
`
`Li, J., Crasto, C.F., Weinberg, J.S., Amiji, M., Shenoy, D., Sridhar, S., Bubbley, G.J., and Jones, G.B. An approach to
`heterobifunctional poly(ethylene glycol) bioconjugates. Bioorganic and Medicinal Chemistry Letters, 15: 5558-5561
`(2005).
`
`
`Bhavsar, M.D., Tiwari, S.B., and Amiji, M.M. Formulation optimization for the nanoparticles-in-microsphere hybrid oral
`delivery system using factorial design. Jo